← Patent-cliff monitor small molecule FERRIPROX DEFERIPRONE
Loss of exclusivity October 2038 latest FDA-listed patent expiry
Drug detail Brand name FERRIPROX Active ingredient DEFERIPRONE Strength 1GM Dosage form TABLET Route ORAL Modality Small molecule FDA approval May 2020 Marketing status RX
Listed patents Patent Expires Type 11723874 October 2038 use U-3083 11357731 October 2038 use U-3083 10940115 October 2038 product 10780055 October 2038 product 11458103 October 2038 product 10940116 October 2038 product
Regulatory exclusivity Code Expires ODE-417 April 2028 ODE-420 April 2028 ODE-421 April 2028
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.